Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow (original) (raw)

Abstract

Gaucher disease, a lysosomal glycolipid storage disorder, results from the genetic deficiency of an acidic glucosidase, glucocerebrosidase (GC). The beneficial effects of allogeneic bone marrow transplantation (BMT) for Gaucher disease suggest that GC gene transduction and the transplantation of autologous hematopoietic stem cells (gene therapy) may similarly alleviate symptoms. We have constructed a retroviral vector, L-GC, produced by a clone of the amphotropic packaging cell line PA317, which transduces the normal human GC cDNA with high efficiency. Whole-marrow mononuclear cells and CD34-enriched cells from a 4-yr-old female with type 3 Gaucher disease were transduced by the L-GC vector and studied in long-term bone marrow culture (LTBMC). Prestimulation of marrow with IL-3 and IL-6, followed by co-cultivation with vector-producing fibroblasts, produced gene transfer into 40-45% of the hematopoietic progenitor cells. The levels of GC expression in progeny cells (primarily mature myelomonocytic) produced by the LTBMC were quantitatively analyzed by Northern blot, Western blot, and glucocerebrosidase enzyme assay. Normal levels of GC RNA, immunoreactive protein, and enzymatic activity were detected throughout the duration of culture. These studies demonstrate that retroviral vectors can efficiently transfer the GC gene into long-lived hematopoietic progenitor cells from the bone marrow of patients with Gaucher disease and express physiologically relevant levels of GC enzyme activity.

342

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts J. M., Donker-Koopman W. E., van der Vliet M. K., Jonsson L. M., Ginns E. I., Murray G. J., Barranger J. A., Tager J. M., Schram A. W. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen. Eur J Biochem. 1985 Aug 1;150(3):565–574. doi: 10.1111/j.1432-1033.1985.tb09058.x. [DOI] [PubMed] [Google Scholar]
  2. Bender M. A., Gelinas R. E., Miller A. D. A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol. 1989 Apr;9(4):1426–1434. doi: 10.1128/mcb.9.4.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood. 1991 Apr 15;77(8):1717–1722. [PubMed] [Google Scholar]
  4. Beutler E. Gaucher's disease. N Engl J Med. 1991 Nov 7;325(19):1354–1360. doi: 10.1056/NEJM199111073251906. [DOI] [PubMed] [Google Scholar]
  5. Beutler E., Kuhl W., Trinidad F., Teplitz R., Nadler H. Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. Am J Hum Genet. 1971 Jan;23(1):62–66. [PMC free article] [PubMed] [Google Scholar]
  6. Bodine D. M., Karlsson S., Nienhuis A. W. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8897–8901. doi: 10.1073/pnas.86.22.8897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Choudary P. V., Barranger J. A., Tsuji S., Mayor J., LaMarca M. E., Cepko C. L., Mulligan R. C., Ginns E. I. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts. Mol Biol Med. 1986 Jun;3(3):293–299. [PubMed] [Google Scholar]
  9. Correll P. H., Kew Y., Perry L. K., Brady R. O., Fink J. K., Karlsson S. Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells. Hum Gene Ther. 1990 Fall;1(3):277–287. doi: 10.1089/hum.1990.1.3-277. [DOI] [PubMed] [Google Scholar]
  10. Cournoyer D., Scarpa M., Mitani K., Moore K. A., Markowitz D., Bank A., Belmont J. W., Caskey C. T. Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum Gene Ther. 1991 Fall;2(3):203–213. doi: 10.1089/hum.1991.2.3-203. [DOI] [PubMed] [Google Scholar]
  11. Dick J. E., Kamel-Reid S., Murdoch B., Doedens M. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood. 1991 Aug 1;78(3):624–634. [PubMed] [Google Scholar]
  12. Dick J. E., Lapidot T., Pflumio F. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: development of animal models for human hematopoiesis. Immunol Rev. 1991 Dec;124:25–43. doi: 10.1111/j.1600-065x.1991.tb00614.x. [DOI] [PubMed] [Google Scholar]
  13. Fabbro D., Desnick R. J., Grabowski G. A. Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting. Am J Hum Genet. 1987 Jan;40(1):15–31. [PMC free article] [PubMed] [Google Scholar]
  14. Fink J. K., Correll P. H., Perry L. K., Brady R. O., Karlsson S. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2334–2338. doi: 10.1073/pnas.87.6.2334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grabowski G. A., Gatt S., Horowitz M. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol. 1990;25(6):385–414. doi: 10.3109/10409239009090616. [DOI] [PubMed] [Google Scholar]
  16. Graves P. N., Grabowski G. A., Ludman M. D., Palese P., Smith F. I. Human acid beta-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts. Am J Hum Genet. 1986 Dec;39(6):763–774. [PMC free article] [PubMed] [Google Scholar]
  17. Karlsson S., Bodine D. M., Perry L., Papayannopoulou T., Nienhuis A. W. Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6062–6066. doi: 10.1073/pnas.85.16.6062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood. 1991 Nov 15;78(10):2481–2492. [PubMed] [Google Scholar]
  19. Mann R., Mulligan R. C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 1983 May;33(1):153–159. doi: 10.1016/0092-8674(83)90344-6. [DOI] [PubMed] [Google Scholar]
  20. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988 Sep 23;241(4873):1632–1639. doi: 10.1126/science.241.4873.1632. [DOI] [PubMed] [Google Scholar]
  21. Miller A. D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol. 1986 Aug;6(8):2895–2902. doi: 10.1128/mcb.6.8.2895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90. [PMC free article] [PubMed] [Google Scholar]
  23. Nolta J. A., Kohn D. B. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther. 1990 Fall;1(3):257–268. doi: 10.1089/hum.1990.1.3-257. [DOI] [PubMed] [Google Scholar]
  24. Nolta J. A., Kohn D. B. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther. 1990 Fall;1(3):257–268. doi: 10.1089/hum.1990.1.3-257. [DOI] [PubMed] [Google Scholar]
  25. Nolta J. A., Sender L. S., Barranger J. A., Kohn D. B. Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer. Blood. 1990 Feb 1;75(3):787–797. [PubMed] [Google Scholar]
  26. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science. 1986 Jun 13;232(4756):1373–1378. doi: 10.1126/science.3520819. [DOI] [PubMed] [Google Scholar]
  27. Rappeport J. M., Barranger J. A., Ginns E. I. Bone marrow transplantation in Gaucher disease. Birth Defects Orig Artic Ser. 1986;22(1):101–109. [PubMed] [Google Scholar]
  28. Reiner O., Wigderson M., Horowitz M. Structural analysis of the human glucocerebrosidase genes. DNA. 1988 Mar;7(2):107–116. doi: 10.1089/dna.1988.7.107. [DOI] [PubMed] [Google Scholar]
  29. Ringdén O., Groth C. G., Erikson A., Bäckman L., Granqvist S., Månsson J. E., Svennerholm L. Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation. 1988 Jul;46(1):66–70. doi: 10.1097/00007890-198807000-00011. [DOI] [PubMed] [Google Scholar]
  30. Sorge J., Kuhl W., West C., Beutler E. Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer. Proc Natl Acad Sci U S A. 1987 Feb;84(4):906–909. doi: 10.1073/pnas.84.4.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sorge J., West C., Westwood B., Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7289–7293. doi: 10.1073/pnas.82.21.7289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Strauss L. C., Trischmann T. M., Rowley S. D., Wiley J. M., Civin C. I. Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):217–221. doi: 10.1097/00043426-199122000-00018. [DOI] [PubMed] [Google Scholar]
  33. Suda T., Suda J., Ogawa M. Proliferative kinetics and differentiation of murine blast cell colonies in culture: evidence for variable G0 periods and constant doubling rates of early pluripotent hemopoietic progenitors. J Cell Physiol. 1983 Dec;117(3):308–318. doi: 10.1002/jcp.1041170305. [DOI] [PubMed] [Google Scholar]
  34. Sutherland H. J., Eaves C. J., Eaves A. C., Dragowska W., Lansdorp P. M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 1989 Oct;74(5):1563–1570. [PubMed] [Google Scholar]
  35. Tsuji S., Choudary P. V., Martin B. M., Winfield S., Barranger J. A., Ginns E. I. Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem. 1986 Jan 5;261(1):50–53. [PubMed] [Google Scholar]
  36. Weinthal J., Nolta J. A., Yu X. J., Lilley J., Uribe L., Kohn D. B. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells. Bone Marrow Transplant. 1991 Nov;8(5):403–412. [PubMed] [Google Scholar]
  37. Williams D. A. Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum Gene Ther. 1990 Fall;1(3):229–239. doi: 10.1089/hum.1990.1.3-229. [DOI] [PubMed] [Google Scholar]